Integrating MAPK pathway inhibition into standard-of-care therapy for pediatric low-grade glioma

Authors

• Erin E Crotty, University of Washington - Seattle Campus
• Aimee A Sato, University of Washington - Seattle Campus
• Mohamed S Abdelbaki, Washington University School of Medicine in St. Louis

Journal

Frontiers in Oncology

Publication Date

1-1-2025

Volume

15

First Page

1520316

Document Type

Open Access Publication

DOI

10.3389/fonc.2025.1520316

Rights and Permissions

Crotty EE, Sato AA and Abdelbaki MS (2025) Integrating MAPK pathway inhibition into standard-of-care therapy for pediatric low-grade glioma. Front. Oncol. 15:1520316. doi: 10.3389/fonc.2025.1520316 © 2025 Crotty, Sato and Abdelbaki. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Recommended Citation

Crotty, Erin E; Sato, Aimee A; and Abdelbaki, Mohamed S, "Integrating MAPK pathway inhibition into standard-of-care therapy for pediatric low-grade glioma." Frontiers in Oncology. 15, 1520316 (2025).
https://digitalcommons.wustl.edu/oa_4/7528